Alimera Sciences (ALIM)
Alimera Sciences Cash and ST Investments: 27.62M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ALIM Cash and ST Investments Rankings
| Overall | 29th percentile | 3094 of 4365 |
| Sector | 34th percentile | 331 of 504 in Healthcare |
| Industry | 16th percentile | 21 of 25 in Drug Manufacturers - Major |
ALIM Cash and ST Investments Range, Past 5 Years
| Minimum | 4.858M | Dec 2009 |
| Maximum | 60.18M | Jun 2010 |
| Average | 38.30M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these ALIM related companies
ALIM News
Listen to $ALIM Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3mi4
about 16 days ago by earningscast
about 16 days ago by earningscast
Trading Radar for 05/11: Gordmans (GMAN), Dr. Reddys (RDY), Cache (CACH), Osiris Therapeutics (OSIR) Report
May 10, 5:52PM Street Insider
May 10, 5:52PM Street Insider
United Kingdom Grants ILUVIEN(R) Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema
May 07, 8:30AM GlobeNewswire
May 07, 8:30AM GlobeNewswire
$ALIM filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aSl
about 27 days ago by MarketBrief
about 27 days ago by MarketBrief
Alimera Sciences to Release First Quarter Fiscal Year 2012 Financial Results
Apr 26, 7:00AM GlobeNewswire
Apr 26, 7:00AM GlobeNewswire
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
Apr 24, 8:30AM GlobeNewswire
Apr 24, 8:30AM GlobeNewswire
pSivida (PSDV) Rips Again; Traders Eye Further European Approval for ILLUVIEN (ALIM)
Mar 27, 12:00PM Street Insider
Mar 27, 12:00PM Street Insider
Healthcare investors and capitalists actively looking for the next generation of market movers
Mar 23, 10:10AM Thomson Reuters ONE
Mar 23, 10:10AM Thomson Reuters ONE
$ALIM forms bullish "Flag" chart pattern. http://stks.co/31zx
about 65 days ago by RecogniaEvents
about 65 days ago by RecogniaEvents
Monday's High Tight Flags $BCRX $ALIM $KTCC $VVUS $OREX http://chart.ly/spytjaq
about 76 days ago by Woodshedder
about 76 days ago by Woodshedder
Listen to $ALIM Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2kCV
about 80 days ago by earningscast
about 80 days ago by earningscast
Douglas Godshall new board of director for $psdv and $alim is boosting $psdv.
about 82 days ago by ingramout
about 82 days ago by ingramout
@mb_willoughby Are you going to hold on to $ALIM for long run or day trade on patterns?
about 82 days ago by Mirac
about 82 days ago by Mirac
Alimera Sciences to Present at 32nd Annual Cowen & Company Health Care Conference
Mar 05, 10:15AM GlobeNewswire
Mar 05, 10:15AM GlobeNewswire
Alimera Sciences (ALIM) Moves up 130% on Week Due to Positive Results for Decentralized Procedure for ILUVIEN
Feb 28, 10:10AM Street Insider
Feb 28, 10:10AM Street Insider
Alimera Sciences (ALIM) Gets Positive Outcome for DCP of ILUVIEN in Europe
Feb 28, 6:45AM Street Insider
Feb 28, 6:45AM Street Insider
Alimera Sciences to Release Fourth Quarter and Fiscal Year 2011 Financial Results
Feb 21, 7:00AM GlobeNewswire
Feb 21, 7:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALIM | 2.63 | +0.00 | +0.00% | 82.66M |
| ALGT | 64.04 | -0.21 | -0.33% | 1.222B |
| ALG | 30.55 | -0.06 | -0.20% | 362.93M |
| ALEX | 50.87 | -0.34 | -0.66% | 2.130B |
| ALE | 38.80 | +0.10 | +0.26% | 1.474B |
| ALD | 50.08 | -0.03 | -0.06% | |
| ALCO | 24.62 | -0.31 | -1.24% | 180.96M |
| ALC | 14.57 | -0.13 | -0.88% | 334.67M |
| AEG | 4.30 | -0.01 | -0.23% | 8.211B |
| AEE | 32.06 | +0.02 | +0.06% | 7.779B |
